6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
6m ago	Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
6m ago	LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
6m ago	KKR Sells CIRCOR Aerospace to Parker Hannifin for $2.55 Billion
7m ago	Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway
7m ago	Intuitive Announces Innovations to Advance Quintuple Aim

About

5.16USD+0.46 +9.79%

Closed • Updated at 13:22 GMT+00:00

Market Cap$426.07M

Volume6.04M

Beta-3.69

RSI58.65

Health TechnologyBiotechnology

Replimune Group, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference

Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025)

Community Chat

Ask AI